Europe Wearable Injectors Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Wearable Injectors Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Wearable Injectors Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Wearable Injectors Market Regional Analysis

6.2 Europe Wearable Injectors Market Revenue 2017-2027 (US$ Million)

6.3 Europe Wearable Injectors Market Forecast Analysis

7. Europe Wearable Injectors Market Analysis – by Type

7.1 On-Body Injectors

7.1.1 Overview
7.1.2 On-Body Injectors: Europe Wearable Injectors Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.2 Off-Body Injectors

7.2.1 Overview
7.2.2 Off-Body Injectors: Europe Wearable Injectors Market – Revenue and Forecast, 2017-2027 (US$ Million)

8. Europe Wearable Injectors Market Analysis – by Application

8.1 Diabetes

8.1.1 Overview
8.1.2 Diabetes: Europe Wearable Injectors Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.2 Oncology

8.2.1 Overview
8.2.2 Oncology: Europe Wearable Injectors Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.3 Cardiovascular Disease

8.3.1 Overview
8.3.2 Cardiovascular Disease: Europe Wearable Injectors Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.4 Autoimmune Disease

8.4.1 Overview
8.4.2 Autoimmune Disease: Europe Wearable Injectors Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.5 Other Applications

8.5.1 Overview
8.5.2 Other Applications: Europe Wearable Injectors Market – Revenue and Forecast, 2017-2027 (US$ Million)

9. Europe Wearable Injectors Market Analysis – by End User

9.1 Hospitals and Clinics

9.1.1 Overview
9.1.2 Hospitals and Clinics: Europe Wearable Injectors Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.2 Homecare Setting

9.2.1 Overview
9.2.2 Homecare Setting: Europe Wearable Injectors Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.3 Other End User

9.3.1 Overview
9.3.2 Other End User: Europe Wearable Injectors Market – Revenue and Forecast, 2017-2027 (US$ Million)

10. Europe Wearable Injectors Market – Europe Analysis

10.1 Overview

10.2 Europe

10.2.1 Europe Wearable Injectors Market Breakdown, by Key Country, 2020 and 2027 (%)
10.2.1.1 Europe Wearable Injectors Market – Revenue and Forecast Analysis – by Country
10.2.1.1 UK: Europe Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.1.1 UK: Europe Wearable Injectors Market Breakdown, by Type
10.2.1.1.2 UK: Europe Wearable Injectors Market Breakdown, by Application
10.2.1.1.3 UK: Europe Wearable Injectors Market Breakdown, by End User

10.2.1.2 Germany: Europe Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.2.1 Germany: Europe Wearable Injectors Market Breakdown, by Type
10.2.1.2.2 Germany: Europe Wearable Injectors Market Breakdown, by Application
10.2.1.2.3 Germany: Europe Wearable Injectors Market Breakdown, by End User

10.2.1.3 France: Europe Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.3.1 France: Europe Wearable Injectors Market Breakdown, by Type
10.2.1.3.2 France: Europe Wearable Injectors Market Breakdown, by Application
10.2.1.3.3 France: Europe Wearable Injectors Market Breakdown, by End User

10.2.1.4 Russia: Europe Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.4.1 Russia: Europe Wearable Injectors Market Breakdown, by Type
10.2.1.4.2 Russia: Europe Wearable Injectors Market Breakdown, by Application
10.2.1.4.3 Russia: Europe Wearable Injectors Market Breakdown, by End User

10.2.1.5 Italy: Europe Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.5.1 Italy: Europe Wearable Injectors Market Breakdown, by Type
10.2.1.5.2 Italy: Europe Wearable Injectors Market Breakdown, by Application
10.2.1.5.3 Italy: Europe Wearable Injectors Market Breakdown, by End User

10.2.1.6 Rest of Europe: Europe Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.6.1 Rest of Europe: Europe Wearable Injectors Market Breakdown, by Type
10.2.1.6.2 Rest of Europe: Europe Wearable Injectors Market Breakdown, by Application
10.2.1.6.3 Rest of Europe: Europe Wearable Injectors Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 BD

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 CeQur SA

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Debiotech S.A

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 E3D Elcam Drug Delivery Devices

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Insulet Corporation

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Gerresheimer AG

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Tandem Diabetes Care Inc

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Zealand Pharma A/S

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 West Pharmaceutical Services, Inc

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Ypsomed AG

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

13.11 Medtronic

13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments

13.12 Amgen, Inc

13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

Europe Wearable Injectors Market

Analysis By Type (On-Body Injectors, Off-Body Injectors); Application (Diabetes, Oncology, Cardiovascular Disease, Autoimmune Disease, Other Applications); End User (Hospitals and Clinics, Homecare Setting, Other End User), and Country